JPMorgan Chase & Co’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $823 | Hold |
619
| – | – | ﹤0.01% | 5752 |
|
|
2025
Q1 | $737 | Hold |
619
| – | – | ﹤0.01% | 5785 |
|
|
2024
Q4 | $1.01K | Hold |
619
| – | – | ﹤0.01% | 5680 |
|
|
2024
Q3 | $2.37K | Hold |
619
| – | – | ﹤0.01% | 5538 |
|
|
2024
Q2 | $1.81K | Sell |
619
-11,203
| -95% | -$32.8K | ﹤0.01% | 5525 |
|
|
2024
Q1 | $46.8K | Sell |
11,822
-8,253
| -41% | -$32.7K | ﹤0.01% | 5004 |
|
|
2023
Q4 | $99.8K | Buy |
20,075
+1,951
| +11% | +$9.7K | ﹤0.01% | 4766 |
|
|
2023
Q3 | $91.5K | Sell |
18,124
-4,159
| -19% | -$21K | ﹤0.01% | 4656 |
|
|
2023
Q2 | $112K | Buy |
+22,283
| New | +$112K | ﹤0.01% | 4590 |
|
|
2018
Q2 | – | Sell |
-1,288
| Closed | -$31K | – | 4818 |
|
|
2018
Q1 | $31K | Sell |
1,288
-17,260
| -93% | -$415K | ﹤0.01% | 4298 |
|
|
2017
Q4 | $3.48M | Sell |
18,548
-406
| -2% | -$76.1K | ﹤0.01% | 2466 |
|
|
2017
Q3 | $4.06M | Buy |
18,954
+13,093
| +223% | +$2.81M | ﹤0.01% | 2285 |
|
|
2017
Q2 | $1.2M | Sell |
5,861
-173
| -3% | -$35.5K | ﹤0.01% | 2824 |
|
|
2017
Q1 | $1.1M | Sell |
6,034
-363
| -6% | -$66.1K | ﹤0.01% | 2860 |
|
|
2016
Q4 | $1.6M | Buy |
6,397
+128
| +2% | +$32K | ﹤0.01% | 2799 |
|
|
2016
Q3 | $1.31M | Buy |
6,269
+423
| +7% | +$88.1K | ﹤0.01% | 2647 |
|
|
2016
Q2 | $1.18M | Sell |
5,846
-212
| -3% | -$42.9K | ﹤0.01% | 2693 |
|
|
2016
Q1 | $1.11M | Buy |
6,058
+294
| +5% | +$53.8K | ﹤0.01% | 2638 |
|
|
2015
Q4 | $1.44M | Buy |
+5,764
| New | +$1.44M | ﹤0.01% | 2532 |
|